Contact: [email protected]
| Title | Tumor type | Line | Study information |
|---|---|---|---|
| ADDIT-Glio | Glioblastoma | Adjuvant | Start of chemoRT ≥ 28d and <50d following surgery; adjuvant WT1 mRNA-loaded dendritic cell vaccination + temozolomide following surgery and chemoRT |
Contact: [email protected]
| Title | Tumor type | Line | Study information |
|---|---|---|---|
| ADDIT-Glio | Glioblastoma | Adjuvant | Start of chemoRT ≥ 28d and <50d following surgery; adjuvant WT1 mRNA-loaded dendritic cell vaccination + temozolomide following surgery and chemoRT |